{"id":3756,"date":"2018-01-26T08:33:29","date_gmt":"2018-01-26T13:33:29","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=3756"},"modified":"2018-01-26T09:21:29","modified_gmt":"2018-01-26T14:21:29","slug":"ipo-pipeline-update-week-ending-1-26-18","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/ipo-pipeline-update-week-ending-1-26-18\/","title":{"rendered":"IPO Pipeline Update – Week Ending 1.26.18"},"content":{"rendered":"


\n<\/a>IPO Boutique keeps apprised of the active pipeline. Currently there are 61 active IPOs in the pipeline as of January 26, 2018. No SPACs or Unit Offerings are included. While the numbers may look diminished, we outlined why \u201clooks may be perceiving\u201d when it comes to the IPO pipeline\u00a0in this article.<\/strong><\/a><\/p>\n

\"Screen<\/a>
\n<\/a>
\nNEW FILINGS<\/strong><\/span><\/p>\n

None This Week<\/p>\n

UPDATED TERMS<\/strong><\/span><\/p>\n

Company: VICI Properties Inc.
\nSymbol: VICI
\nDescription: They are an owner, acquirer and developer of experiential real estate assets across leading gaming, hospitality, entertainment and leisure destinations.
\nShares: 50 million
\nPrice Range: $19.00-$21.00
\nTrade Date: 2\/1
\nUnderwriter(s): Morgan Stanley, Goldman Sachs & Co., BofA Merrill Lynch, Barclays, Citigroup, Deutsche Bank Securities
\nCo-Manager(s): Credit Suisse, UBS Investment Bank, Stifel, Citizens Capital Markets, Wells Fargo Securities, Nomura, Union Gaming
\nTerms Added: 1-22-18<\/p>\n

Company: Genprex, Inc.
\nSymbol: GNPX
\nDescription: Genprex is a clinical stage gene therapy company developing a new approach to treating cancer, based upon their novel proprietary technology platform, including their initial product candidate, Oncoprex immunogene therapy, or Oncoprex.
\nShares: 1.3 million
\nRange: $5.00-$5.00
\nTrade Date: 1\/31
\nUnderwriter(s): Network 1 Financial Securities
\nTerms Added: 1-22-18<\/p>\n

Company: Sol-Gel Technologies, Ltd.
\nSymbol: SLGL
\nDescription: They are a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases
\nShares: 5 million
\nPrice Range: $11.00-$13.00
\nTrade Date: 2\/1
\nUnderwriter(s): Jefferies, BMO Capital Markets
\nCo-Manager(s): JMP Securities, Raymond James
\nTerms Added: 1-23-18<\/p>\n

Company: FTS International
\nSymbol: FTS
\nDescription: FTS International is an independent provider of oil and natural gas well stimulation services with expertise in high-pressure hydraulic fracturing.
\nShares: 15.2 million
\nPrice Range: $15.00-$18.00
\nTrade Date: 2\/2
\nUnderwriter(s): Credit Suisse, Morgan Stanley
\nCo Manager(s): Wells Fargo, Barclays, Citigroup, Evercore ISI, Guggenheim Securities, Simmons & Co., Tudor Pickering Holt, Cowen and Company
\nTerms Added: 1-23-18<\/p>\n

Company: Bioceres S.A.
\nSymbol: BIOX
\nDescription: They are a fully-integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants and fertilizers.
\nShares: 11.8 million
\nPrice Range: $10.00-$12.00
\nTrade Date: 2\/7
\nUnderwriter(s): Jefferies, Piper Jaffray, Santander, SunTrust Robinson Humprhey
\nCo-Manager: Mirabaud Securities
\nTerms Added: 1-23-18<\/p>\n

Company: TFI TAB Food Investments
\nSymbol: QSRG
\nDescription: They are one of the world’s largest global restaurant operators by number of restaurants and the largest Restaurant Brands International, or RBI, franchisee globally.
\nUnderwriter(s): Morgan Stanley, Credit Suisse, Goldman Sachs & Co., Citigroup, J.P. Morgan, Rabo Securities
\nShares: 22 million ADS
\nPrice Range: $9.00-$11.00
\nTrade Date: 2\/7
\nTerms Added: 1-26-18<\/p>\n

Company: Biofrontera AG
\nSymbol: BFRA
\nDescription: They are an international biopharmaceutical company specializing in the development and commercialization of a platform of pharmaceutical products for the treatment of dermatological conditions and diseases caused primarily by exposure to sunlight that results in sun damage to the skin.
\nTrade Date: TBD
\nShares: TBD
\nPrice Range: $8.80-$10.80
\nUnderwriter(s): Benchmark
\nCo-Manager(s): Dawson James Securities, Lake Street Capital Markets
\nFiled: 1-26-18<\/p>\n","protected":false},"excerpt":{"rendered":"

IPO Boutique keeps apprised of the active pipeline. Currently there are 61 active IPOs in the pipeline as of January 26, 2018. No SPACs or Unit Offerings are included. While the numbers may look diminished, we outlined why \u201clooks may be perceiving\u201d when it comes to the IPO pipeline\u00a0in this article. NEW FILINGS None This[…]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[24],"tags":[],"class_list":["post-3756","post","type-post","status-publish","format-standard","hentry","category-ipo"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3756","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=3756"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3756\/revisions"}],"predecessor-version":[{"id":3758,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3756\/revisions\/3758"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=3756"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=3756"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=3756"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}